← REGULATORY CHANGES
FEDERAL REGISTER · RULEJuly 10, 2024IN FORCE

Advisory Committee; Allergenic Products Advisory Committee; Termination; Removal From List of Standing Committees

What this record is not

Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.

STATUSIN FORCE
EFFECTIVEJul 10, 2024
COMMENTS CLOSE—
APPLIES TO · SPEQ TAGBiologicsFood
Document type
Rule
Agency
Health and Human Services Department
Published
July 10, 2024
Effective
July 10, 2024
Document number
2024-15136
CFR references
21 CFR 14
Docket
FDA-2024-N-3008
ABSTRACT

The Food and Drug Administration (FDA or Agency) is announcing the termination of the Allergenic Products Advisory Committee, Center for Biologics Evaluation and Research. This document announces the reasons for termination and removes the Allergenic Products Advisory Committee from the Agency's list of standing advisory committees.

Abstract as published in the Federal Register.

READ THE FULL DOCUMENT

The complete document — every provision, the docket, and the comment instructions — is published in the Federal Register. SPEQ surfaces and indexes it for reference; the authoritative text lives on federalregister.gov.

View on federalregister.gov →

That is what FDA published. A free account files it on your watchlist and sends one weekly email with whatever lands next.

Create a free account